Bennett G, O'Shaughnessy D
J Cell Biol. 1981 Jan;88(1):1-15. doi: 10.1083/jcb.88.1.1.
To study the site of incorporation of sialic acid residues into glycoproteins in hepatocytes, we gave 40-g rats and 15-g Swiss albino mice a single intravenous injection of [3H]N-acetylmannosamine (8 mCi) and then sacrificed them after 2 and 10 min. To trace the subsequent migration of the labeled glycoproteins, we injected 40-g rats with 4 mCi of [3H]N-acetylmannosamine and sacrificed them after 20 and 30 min, 1, 4, and 24 h, and 3 and 9 d. Concurrent biochemical experiments were carried out to test the specificity of injected [3H]N-acetylmannosamine as a precursor for sialic acid residues of glycoproteins. In radioautographs from rats and mice sacrificed 10 min after injection, grain counts showed that over 69% of the silver grains occurred over the Golgi region. The majority of these grains were localized over the trans face of the Golgi stack, as well as over associated secretory vesicles and possibly GERL. In rats, the proportion of grains over the Golgi region decreased with time to 37% at 1 h, 11% at 4 h, and 6% at 24 h. Meanwhile, the proportion of grains over the plasma membrane increased from 4% at 10 min to 29% at 1 h and over 55% at 4 and 24 h; two-thirds of these grains lay over the sinusoidal membrane, and the remainder were equally divided over the lateral and bile canalicular membranes. Many silver grains also appeared over lysosomes at the 4- and 24-h time intervals, accounting for 15-17% of the total. At 3 and 9 d after injection, light microscope radioautographs revealed a grain distribution similar to that seen at 24 h, with a progressive decrease in the intensity of labeling such that by 9 d only a very light reaction remained. Because our biochemical findings indicated that [3H]N-acetylmannosamine is a fairly specific precursor for the sialic acid residues of glycoproteins (and perhaps glycolipids), the interpretation of these results is that sialic acid is incorporated into these molecules in the Golgi apparatus and that the latter then migrate to secretion products, to the plasma membrane, and to lysosomes in a process of continuous renewal. It is possible that some of the label seen in lysosomes at later time intervals may have been derived from the plasma membrane or from material arising outside the cells.
为研究肝细胞中唾液酸残基掺入糖蛋白的部位,我们给40克重的大鼠和15克重的瑞士白化小鼠单次静脉注射[³H]N - 乙酰甘露糖胺(8毫居里),然后在2分钟和10分钟后将它们处死。为追踪标记糖蛋白随后的迁移情况,我们给40克重的大鼠注射4毫居里的[³H]N - 乙酰甘露糖胺,并在20分钟、30分钟、1小时、4小时、24小时以及3天和9天后将它们处死。同时进行了生化实验,以测试注射的[³H]N - 乙酰甘露糖胺作为糖蛋白唾液酸残基前体的特异性。在注射后10分钟处死的大鼠和小鼠的放射自显影片中,颗粒计数显示超过69%的银颗粒出现在高尔基体区域。这些颗粒大多位于高尔基体堆叠的反面,以及相关的分泌小泡和可能的GERL上。在大鼠中,高尔基体区域的颗粒比例随时间下降,1小时时降至37%,4小时时降至11%,24小时时降至6%。与此同时,质膜上的颗粒比例从10分钟时的4%增加到1小时时的29%,在4小时和24小时时超过55%;其中三分之二的颗粒位于窦状膜上,其余的平均分布在侧面和胆小管膜上。在4小时和24小时的时间间隔内,许多银颗粒也出现在溶酶体上,占总数的15% - 17%。在注射后3天和9天,光学显微镜放射自显影片显示颗粒分布与24小时时相似,标记强度逐渐降低,到9天时仅留下非常微弱的反应。因为我们的生化研究结果表明[³H]N - 乙酰甘露糖胺是糖蛋白(可能还有糖脂)唾液酸残基的相当特异的前体,所以对这些结果的解释是唾液酸在高尔基体中掺入这些分子,然后高尔基体在持续更新的过程中迁移到分泌产物、质膜和溶酶体。后期时间间隔内在溶酶体中看到的一些标记可能来自质膜或细胞外产生的物质。